Bristol-Myers Squib - Paclitaxel
There is truly just one acquirer that would make a lot of sense Bristol-Myers Squib, owner of Paclitaxel (chemo drug).
Pela would serious increase Paclitaxel drug and extend patent life. So, just do the deal and that's it.
No more putting on cheap lingerie and make yourself pretty. No more courting Checkpoint inbititors. Make the deal with Bristol-Myers Squib.
Shareholders have waited long enough and deserve a pay day.